SCHEMBL142665

SCHEMBL142665

OB(O)c1ccc(OCc2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.66
CYP1A2 P05177 1/20 0.66
PTGS1 P23219 1/20 0.66
SLC6A2 P23975 1/20 0.66
CYP2C19 P33261 1/20 0.66
PTGS2 P35354 1/20 0.66
SLC6A3 Q01959 1/20 0.66
HIF1A Q16665 1/20 0.66
HDAC6 Q9UBN7 1/20 0.66
MAOB P27338 4/20 0.58
GAA P10253 1/20 0.58
MAPT P10636 1/20 0.58
MAOA P21397 1/20 0.58
RAB9A P51151 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
NR4A1 P22736 1/20 0.58
NR4A2 P43354 1/20 0.58
NR4A3 Q92570 1/20 0.58
CA1 P00915 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15333100 0.95 CA1 (0.67) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL2555201 0.95 LMNA (0.59) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL177615 0.92 APP (0.58) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL13903287 0.92 CYP1A2 (0.56) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL12420267 0.90 APP (0.54) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL6059706 0.89 CYP1A2 (0.66) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL7277339 0.85 CYP1A2 (0.61) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL4817895 0.84 CA1 (0.49) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL257567 0.84 ALOX5 (0.67) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL29954530 0.84 ALOX5 (0.67) LMNACYP1A2PTGS1SLC6A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250194617-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-06-19 US claimed
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US claimed
CN-119674208-A PEO-PAN-based polymer electrolyte membrane and preparation method and application thereof 山东创鲁先进电池科技有限公司 2025-03-21 CN claimed
CN-117643584-A Preparation method of sulfachromone compound for candida albicans resistant medicine 广西民族大学 2024-03-05 CN claimed
WO-2024016826-A1 6-POSITION SUBSTITUTED DIHYDROBENZO[E][1,2,3]OXATHIAZINE 2,2-DIOXIDE COMPOUND, PREPARATION THEREFOR, AND USE THEREOF 杭州市第七人民医院 2024-01-25 WO claimed
US-20230380457-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-30 US claimed
EP-4280882-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2023-11-29 EP claimed
US-20230363426-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-16 US claimed
US-11793220-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2023-10-24 US claimed
CN-116916755-A Materials and methods for extending the shelf life of food products JP实验室公司 2023-10-20 CN claimed
US-20220225647-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
CN-113444125-A Novel phosphoramidite ligand, preparation method thereof and application thereof in asymmetric carbonylation reaction 西北大学 2021-09-28 CN claimed
CN-109988175-A A kind of preparation method for replacing Buddhist nun-d5 according to Shandong 梯尔希(南京)药物研发有限公司 2019-07-09 CN claimed
US-20120100073-A1 PET RADIOTRACERS FOR IMAGING FATTY ACID METABOLISM AND STORAGE WASHINGTON UNIVERSITY (US) 2012-04-26 US claimed
EP-2427218-A2 PET RADIOTRACERS FOR IMAGING FATTY ACID METABLOLISM AND STORAGE Washington University (US) 2012-03-14 EP claimed
WO-2010129572-A2 PET RADIOTRACERS FOR IMAGING FATTY ACID METABLOLISM AND STORAGE WASHINGTON UNIVERSITY (US) 2010-11-11 WO claimed
US-7037905-B2 Pharmaceutical use of boronic acids and esters thereof NOVO NORDISK A/S (DK) 2006-05-02 US claimed
US-20040053889-A1 Pharmaceutical use of boronic acids and esters thereof NOVO NORDISK A/S (DK) 2004-03-18 US claimed
WO-2003105860-A1 PHARMACEUTICAL USE OF BORONIC ACIDS AND ESTERS THEREOF NOVO NORDISK A/S (DK) 2003-12-24 WO claimed
WO-1994010179-A1 ARYLBORON ACIDS AS INTERMEDIATES IN THE PRODUCTION OF COMPONENTS OF LIQUID-CRYSTAL MIXTURES HOECHST AKTIENGESELLSCHAFT (DE) 1994-05-11 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053889-A1 Pharmaceutical use of boronic acids and esters thereof LIPE, CEL, LIPA LMNA 994/4885CYP1A2 781/4885PTGS1 2535/4885
US-20120100073-A1 PET RADIOTRACERS FOR IMAGING FATTY ACID METABOLISM AND STORAGE LIPC, PNLIP, FFAR1 LMNA 3741/4885CYP1A2 1086/4885PTGS1 1472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.